olivLaw · European equity research
Stillfront Group AB (publ) SF.ST
Sweden · Nasdaq Stockholm · ISIN SE0015346135 · Vertical: Listed companies from Sweden
At the close of 09 Nov 2026, Stillfront Group AB (publ) (SF.ST) stock was 6.29 SEK (+3.97% on the day), with market capitalisation 3.2 bn SEK, beta 0.65, 52-week range 3.49–7.66 SEK.
Data as of · Source: ESEF annual reports and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 46.1
- neutral
- Bollinger (20, 2)
- 5.15 – 7.76
- in the lower half of the band · %B 0.44 · band width 40.5%
- SMA 50 / 200
- 6.79 / 5.43
- mixed trend
- MACD (12, 26, 9)
- -0.25 / -0.25
- MACD below signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | EURO STOXX 50 | vs EURO STOXX 50 | Vertical median | |
|---|---|---|---|---|
| 1 month | −17.8% | +1.9% | −19.7 pp | — |
| 3 months | −7.1% | −3.8% | −3.3 pp | — |
| 6 months | +11.1% | +6.7% | +4.4 pp | — |
| Year to date | −3.2% | +8.5% | −11.8 pp | — |
| 1 year | +0.2% | +13.0% | −12.8 pp | −7.9% |
| 3 years | −45.9% | +49.9% | −95.8 pp | +12.9% |
| 5 years | −85.3% | +44.6% | −129.9 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 7.1 bn | 7.0 bn | 6.7 bn | 5.7 bn |
| Revenue YoY | unavailable | −1.1% | −3.5% | −15.2% |
| Net income | 559.0 m | 7.0 m | -7.4 bn | -2.4 bn |
| Net income YoY | unavailable | −98.7% | −105,500.0% | unavailable |
| Diluted EPS | 1.15 | 0.01 | -14.40 | -4.75 |
| Diluted EPS YoY | unavailable | −99.1% | −144,100.0% | unavailable |
| net % | 7.9% | 0.1% | -109.5% | -42.0% |
| Free cash flow | unavailable | unavailable | unavailable | unavailable |
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 701.0 m SEK
- Financial debt
- 984.0 m SEK
- Net debt
- 283.0 m SEK
- Equity
- 4.0 bn SEK
- Total assets
- 11.0 bn SEK
- Debt / equity
- 0.25x
- Current ratio
- 0.95x
- ROE
- -41.8%
- ROA
- -17.5%
- FCF margin
- unavailable
Financial statements (source on every figure)
Revenue and net income (SEK)
Margins
Income statement · SEK
| Line | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|
| Revenue | 7.1 bn | 7.0 bn | 6.7 bn | 5.7 bn | esef· 28 Oct 2026verified |
| Operating income | 850.0 m | 754.0 m | -6.5 bn | -1.7 bn | esef· 28 Oct 2026verified |
| Depreciation & amortisation | 1.7 bn | 1.7 bn | — | — | esef· 09 Jul 2024verified |
| EBITDA | 2.5 bn ≈ | 2.4 bn ≈ | — | — | esef· 09 Jul 2024derived |
| Interest expense | 353.0 m | 672.0 m | 961.0 m | 704.0 m | esef· 28 Oct 2026verified |
| Pre-tax income | 752.0 m | 156.0 m | -7.4 bn | -2.4 bn | esef· 28 Oct 2026verified |
| Income tax | 206.0 m | 143.0 m | 27.0 m | 6.0 m | esef· 28 Oct 2026verified |
| Net income | 559.0 m | 7.0 m | -7.4 bn | -2.4 bn | esef· 28 Oct 2026verified |
| Diluted EPS | 1.15 | 0.01 | -14.40 | -4.75 | esef· 28 Oct 2026verified |
| Weighted average diluted shares | 483.9 m | 512.2 m | 512.3 m | 504.7 m | esef· 28 Oct 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · SEK
| Line | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|
| Cash | 989.0 m | 807.0 m | 957.0 m | 701.0 m | esef· 28 Oct 2026verified |
| Current assets | 1.7 bn | 1.6 bn | 1.8 bn | 1.3 bn | esef· 28 Oct 2026verified |
| Property, plant & equipment, net | 56.0 m | 56.0 m | 59.0 m | 47.0 m | esef· 28 Oct 2026verified |
| Goodwill | 16.0 bn | 15.6 bn | 9.9 bn | 6.9 bn | esef· 28 Oct 2026verified |
| Total assets | 24.1 bn | 22.6 bn | 16.4 bn | 11.0 bn | esef· 28 Oct 2026verified |
| Short-term debt | 79.0 m | 27.0 m | 0 | — | esef· 08 May 2025verified |
| Long-term debt | 1.5 bn | 1.7 bn | 1.4 bn | 984.0 m | esef· 28 Oct 2026verified |
| Current liabilities | 2.0 bn | 1.4 bn | 1.9 bn | 1.4 bn | esef· 28 Oct 2026verified |
| Equity | 14.2 bn | 13.8 bn | 7.5 bn | 4.0 bn | esef· 28 Oct 2026verified |
| Shares outstanding at year end | 486.1 m | — | 512.4 m | 504.8 m | esef· 28 Oct 2026derived |
Cash flow · SEK
| Line | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|
| Operating cash flow | 2.0 bn | 1.7 bn | 1.7 bn | 1.5 bn | esef· 28 Oct 2026verified |
| Investing cash flow | -3.8 bn | -1.7 bn | -1.1 bn | -1.1 bn | esef· 28 Oct 2026verified |
| Financing cash flow | 1.5 bn | -175.0 m | -452.0 m | -505.0 m | esef· 28 Oct 2026verified |
| Share repurchases | 0 | 270.0 m | 302.0 m | 248.0 m | esef· 28 Oct 2026verified |
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 41.7% of at least 60%
- valuation methods computed: 0 of at least 1
A scoring methodology on indicators and valuation, not investment advice.
Closing price
09 Nov 2026Source: olivLaw, closing series
Market cap: 3.2 bn SEK
Key indicators
Coverage and freshness
Score by group
42% · Insufficient data
Estimated value range
unavailable — no valuation assumptions for the reporting currency
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
Assumptions (illustrative, editorial)
- Risk-free rate
- 6.5%
- Equity risk premium
- 6.0%
- Beta (default)
- 1.00
- Cost of equity
- 12.5%
- Terminal growth
- 3.0%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 41.7% of at least 60%; valuation methods computed: 0 of at least 1
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | -24.1% | 13 (vs peers) | 25% |
| Net margin · Quality | -42.0% | 8 (vs peers) | 15% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | -6.8% | 0 (on a fixed band) | 20% |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | -2.5x | 0 (on a fixed band) | 15% |
| Current ratio · Balance sheet | 0.9x | 12 (on a fixed band) | 10% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | unavailable | unavailable | — |
| Shareholder yield (distributions) · Returns | 7.8% | 100 (on a fixed band) | 15% |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet5/100 · 2/3 factors with a value
- Growth· partial0/100 · 1/2 factors with a value
- Quality11/100 · 2/3 factors with a value
- Returns· partial100/100 · 1/2 factors with a value
- Valuation· partialunavailable · 0/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
Stillfront Group AB (publ) (SF.ST). Latest full fiscal year: 2025; data up to 2025-12-31.
Figures computed from the financial statements: revenue 5.7 bn SEK in 2025; YoY growth -15.2%; net margin -42.0%; ROE -41.8%.
Valuation cannot be computed from the available data.
Insufficient data for a verdict (score weight coverage: 41.7% of at least 60%; valuation methods computed: 0 of at least 1).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Shareholder yield (distributions): 7.8%
What contradicts it
- ROIC: -24.1%
- Net margin: -42.0%
- Revenue CAGR 3Y: -6.8%
- Interest coverage: -2.5x
- Current ratio: 0.9x
Not assessed (insufficient data or a ratio without meaning): FCF conversion, EPS CAGR 3Y, Net debt / EBITDA, P/E (TTM), EV/EBITDA, FCF yield, Payout ratio (FCF).
Versus the vertical median
Listed companies from Sweden · same country · compared with 39 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| ALFA.STAlfa Laval AB | 221.7 bn | 26.8 | 19.4% | 11.9% | +4.1% | +20% / +37% |
| BOL.STBoliden Ab | 146.4 bn | 15.6 | 13.3% | 10.1% | +4.8% | +15% / +86% |
| CAST.STCastellum Aktiebolag | 66.9 bn | 71.3 | 1.2% | 9.8% | −2.6% | +27% / +6% |
| AAK.STAak Ab (publ) | 47.2 bn | 13.8 | 17.2% | 7.5% | +2.2% | −31% / −15% |
| CAMX.STCamurus AB | 43.9 bn | 60.4 | 19.5% | 32.5% | +21.3% | +20% / +60% |
| BRAV.STBravida Holding AB | 29.4 bn | 23.9 | 13.7% | 4.4% | −4.9% | +80% / +118% |
| ASKER.STAsker Healthcare Group AB | 28.7 bn | 58.4 | 9.8% | 2.9% | +11.7% | −20% / unavailable |
| ALLEI.STAlleima AB | 22.9 bn | 34.1 | 4.1% | 3.6% | −5.4% | +12% / +21% |
| BURE.STBure Equity AB | 22.5 bn | — | -21.0% | — | unavailable | +19% / +19% |
| AQ.STAQ Group AB | 20.4 bn | 30.2 | 14.9% | 7.5% | +6.0% | +18% / +126% |
| ATT.STAttendo AB (publ) | 19.0 bn | 23.5 | 15.1% | 4.3% | +0.1% | +51% / +266% |
| ALTRA.STAltra Fastigheter AB | 18.8 bn | 34.7 | 3.0% | 15.1% | −2.2% | +11% / +22% |
| AFRY.STAfry Ab | 14.9 bn | 18.6 | 6.2% | 3.1% | −5.2% | −17% / +3% |
| ATRLJ-B.STAtrium Ljungberg AB | 14.0 bn | 17.0 | 2.9% | 23.9% | −2.0% | −33% / −45% |
| ACAD.STAcadeMedia AB | 13.1 bn | 15.9 | 12.7% | 4.3% | +9.7% | +26% / +145% |
| ALIG.STAlimak Group AB (publ) | 12.9 bn | 21.6 | 8.2% | 8.8% | −3.2% | −16% / +53% |
| APOTEA.STApotea AB (publ) | 11.0 bn | 48.0 | 31.3% | 3.2% | +10.1% | +18% / unavailable |
| BOOZT.STBoozt AB | 10.7 bn | 38.3 | 10.4% | 3.6% | +0.5% | +59% / +45% |
| BUFAB.STBufab AB (publ) | 5.0 bn | 9.1 | 15.1% | 6.9% | −7.4% | +35% / +108% |
| CEVI.STCellaVision AB | 4.8 bn | 31.2 | 18.0% | 20.2% | +4.9% | +21% / +13% |
| COOR.STCoor Service Management Holding AB | 4.6 bn | 18.1 | 13.0% | 2.2% | +16.7% | +1% / +24% |
| BHG.STBHG Group AB | 4.4 bn | 30.5 | 2.5% | 1.4% | +6.2% | −20% / +109% |
| ACTI.STActive Biotech AB (publ) | 4.3 bn | — | -84.5% | — | unavailable | −41% / −80% |
| SF.STStillfront Group AB (publ) | 3.2 bn | — | -41.8% | -42.0% | −15.2% | −7% / −46% |
| CARA.STCarasent AB (publ) | 1.8 bn | 51.2 | 4.1% | 10.1% | +24.9% | −9% / +86% |
1- and 3-year price returns: for SF.ST from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (SEK)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 3 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 5 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
AI analysis
The qualitative analysis has not been written for this company yet.
Products, market & competition
The qualitative analysis has not been written for this company yet.
News & filings
In the press
No news in our archive over the last 180 days.
Annual reports (ESEF)
- Annual report 202528 Oct 2026
- Annual report 202408 May 2025
- Annual report 202309 Jul 2024
Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.